Tag: CBT > CBD FDA: Page 4

Interviews & Opinion

FDA’s Rejection of CBD New Dietary Ingredient Notifications: Four Practical Takeaways

Kelley Drye & Warren’s Kristi Wolff breaks down the most important aspects of the government agency’s decision on the hemp-derived cannabinoid.

September 17, 2021

Legislation and Regulation

FDA Balks at CBD Dietary Supplement Application, Maintaining Regulatory Uncertainty

Citing its own approval of CBD as an active ingredient in Epidiolex, the FDA sees the cannabinoid as pharmaceutical constituent.

August 12, 2021

CBD Industry

CBD Sales Both Boosted, Thwarted by COVID-19

Price compression and the economic downturn continue to be challenges, though sales volume has increased.

September 28, 2020

Legislation and Regulation

Maine Says Adult-Use Cannabis Sales Will Launch This Fall, Vermont Revisits Legislation to Tax and Regulate Sales: Week in Review

Maine’s Office of Marijuana Policy announced this week that adult-use sales can launch Oct. 9.

August 22, 2020

Compliance

The FDA Wants to Test Thousands of CBD Products on the Market

The move comes as the administration continues to tilt toward some form of federal regulation for the CBD industry.

August 18, 2020

Arizona

Nevada Compliance Board Holds Inaugural Meeting, FDA Issues Much-Anticipated Report: Week in Review

The newly established Nevada Cannabis Compliance Board met for the first time this week and signed off on a disciplinary settlement that will revoke six of CWNevada’s 14 licenses.

July 25, 2020

CBD Industry

FDA Submits ‘Cannabidiol Enforcement Policy’ Draft to White House

While the contents of the document are still unknown, the FDA described it as “draft guidance for the industry.”

July 24, 2020

Legislation and Regulation

Illinois Delays Awarding New Cannabis Dispensary Licenses, Canopy Growth Lays off 200 More Workers: Week in Review

This week, Illinois regulators planned to issue 75 adult-use dispensary licenses, but instead announced that they will now wait until the governor’s disaster proclamation expires.

May 2, 2020

CBD Industry

FDA Warns Two Companies to Stop Marketing CBD as Opioid Addiction Treatment

The letters were sent to BIOTA Biosciences LLC and Homero Corp, the latter of which conducts business as Natures CBD Oil Distribution.

April 30, 2020

Home

End Notes

Quotes you should note.

April 3, 2020

Finance

Charlotte’s Web Reports $18.8M Q4 Loss, Executives Discuss Challenges and the Future

In a recent earnings call, Charlotte’s Web executives discussed a drop in Q4 sales due to regulatory uncertainty, its recent Abacus acquisition and how the coronavirus will impact business.

March 27, 2020

Finance

CV Sciences Reveals FY 2019 Earnings, Discusses Future Amid Coronavirus Outbreak

In a recent earnings call, company executives discussed challenges they endured in 2019 and what they're facing in 2020.

March 19, 2020